Telomere Length as a New Risk Marker of Early-Onset Colorectal Cancer.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
09 Feb 2023
Historique:
received: 07 12 2022
revised: 02 02 2023
accepted: 07 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

Early-onset colorectal cancer (EOCRC; age younger than 50 years) incidence has been steadily increasing in recent decades worldwide. The need for new biomarkers for EOCRC prevention strategies is undeniable. In this study, we aimed to explore whether an aging factor, such as telomere length (TL), could be a useful tool in EOCRC screening. The absolute leukocyte TL from 87 microsatellite stable EOCRC patients and 109 healthy controls (HC) with the same range of age, was quantified by Real Time Quantitative PCR (RT-qPCR). Then, leukocyte whole-exome sequencing (WES) was performed to study the status of the genes involved in TL maintenance (

Identifiants

pubmed: 36834938
pii: ijms24043526
doi: 10.3390/ijms24043526
pmc: PMC9965248
pii:
doi:

Substances chimiques

DKC1 protein, human 0
Biomarkers, Tumor 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI20/0974
Organisme : Instituto de Salud Carlos III
ID : PI20/01569

Références

J Clin Gastroenterol. 2022 Aug 19;:
pubmed: 35997687
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Aging Cell. 2015 Jun;14(3):372-81
pubmed: 25684230
PeerJ. 2015 Mar 03;3:e796
pubmed: 25780760
Transl Oncol. 2022 Oct 8;26:101551
pubmed: 36219936
Front Oncol. 2022 Sep 20;12:962929
pubmed: 36203452
J Med Genet. 2020 Oct;57(10):664-670
pubmed: 31937561
Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1807-13
pubmed: 22911335
Biol Res Nurs. 2022 Oct 10;:10998004221133395
pubmed: 36214766
Endoscopy. 2019 Nov;51(11):1082-1093
pubmed: 31597170
Cancer Discov. 2022 Jan;12(1):31-46
pubmed: 35022204
Ageing Res Rev. 2014 May;15:1-5
pubmed: 24561251
Cancers (Basel). 2023 Jan 16;15(2):
pubmed: 36672501
Cancers (Basel). 2022 Dec 31;15(1):
pubmed: 36612269
Cancers (Basel). 2021 May 25;13(11):
pubmed: 34070516
Nat Protoc. 2010 Sep;5(9):1596-607
pubmed: 21085125
Int J Mol Sci. 2022 Mar 29;23(7):
pubmed: 35409143
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):219-28
pubmed: 20056641
Br J Cancer. 2019 Aug;121(4):344-350
pubmed: 31312029
N Engl J Med. 2022 Apr 21;386(16):1547-1558
pubmed: 35443109
Clin Transl Gastroenterol. 2014 Mar 06;5:e52
pubmed: 24598784

Auteurs

Abel Martel-Martel (A)

Institute of Biomedical Research of Salamanca (IBSAL-SACYL), University of Salamanca-CSIC, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
Molecular Medicine Unit, Department of Medicine, University of Salamanca, 37007 Salamanca, Spain.
Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-CSIC, 37007 Salamanca, Spain.

Luis A Corchete (LA)

Institute of Biomedical Research of Salamanca (IBSAL-SACYL), University of Salamanca-CSIC, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-CSIC, 37007 Salamanca, Spain.

Marc Martí (M)

Department of Surgery, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.

Rosario Vidal-Tocino (R)

Institute of Biomedical Research of Salamanca (IBSAL-SACYL), University of Salamanca-CSIC, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
Medical Oncology Department, Hospital Universitario de Salamanca, 37007 Salamanca, Spain.

Elena Hurtado (E)

Department of Surgery, Hospital Universitario Gregorio Marañón, 28007 Madrid, Spain.

Edurne Álvaro (E)

Department of Surgery, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain.

Fernando Jiménez (F)

Department of Surgery, Hospital Galdakao-Usansolo, 48960 Vizcaya, Spain.

Marta Jiménez-Toscano (M)

Department of Surgery, Hospital del Mar, 08003 Barcelona, Spain.

Francesc Balaguer (F)

Department of Gastroenterology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, 08036 Barcelona, Spain.

Gonzalo Sanz (G)

Department of Surgery, Hospital Clínico San Carlos, 28040 Madrid, Spain.

Irene López (I)

Department of Surgery, Hospital MD Anderson, 28033 Madrid, Spain.

Sergio Hernández-Villafranca (S)

Department of General Surgery and Digestive System, Fundación Jiménez Díaz Hospital, 28040 Madrid, Spain.

Araceli Ballestero (A)

Department of Surgery, Hospital Universitario Ramon y Cajal, 28034 Madrid, Spain.

Alfredo Vivas (A)

Department of Surgery, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.

Sirio Melone (S)

Department of Surgery, Hospital Universitario Fundación Alcorcón, 28922 Madrid, Spain.

Carlos Pastor (C)

Department of Colorectal Surgery, Clínica Universidad de Navarra, 28027 Madrid, Spain.

Lorena Brandáriz (L)

Department of Surgery, Hospital Universitario General de Villalba, 28400 Madrid, Spain.

Manuel A Gómez-Marcos (MA)

Institute of Biomedical Research of Salamanca (IBSAL-SACYL), University of Salamanca-CSIC, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.

Juan J Cruz-Hernández (JJ)

Institute of Biomedical Research of Salamanca (IBSAL-SACYL), University of Salamanca-CSIC, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
Molecular Medicine Unit, Department of Medicine, University of Salamanca, 37007 Salamanca, Spain.
Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-CSIC, 37007 Salamanca, Spain.

José Perea (J)

Institute of Biomedical Research of Salamanca (IBSAL-SACYL), University of Salamanca-CSIC, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.

Rogelio González-Sarmiento (R)

Institute of Biomedical Research of Salamanca (IBSAL-SACYL), University of Salamanca-CSIC, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
Molecular Medicine Unit, Department of Medicine, University of Salamanca, 37007 Salamanca, Spain.
Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-CSIC, 37007 Salamanca, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH